The HER2-Binding Affibody Molecule (ZHER2:342)2 Increases Radiosensitivity in SKBR-3 Cells

15Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

We have previously shown that the HER2-specific affibody molecule (ZHER2:342)2 inhibits proliferation of SKBR-3 cells. Here, we continue to investigate its biological effects in vitro by studying receptor dimerization and clonogenic survival following irradiation. We found that (ZHER2:342)2 sensitizes the HER2-overexpressing cell line SKBR-3 to ionizing radiation. The survival after exposure to (ZHER2:342)2 and 8 Gy (S8Gy 0.006) was decreased by a factor four compared to the untreated (S8Gy 0.023). The low HER2-expressing cell line MCF-7 was more radiosensitive than SKBR-3 but did not respond to (ZHER2:342)2. Treatment by (ZHER2:342)2 strongly increased the levels of dimerized and phosphorylated HER2 even after 5 minutes of stimulation. The monomeric ZHER2:342 does not seem to be able to induce receptor phosphorylation and dimerization or sensitize cells to irradiation. © 2012 Ekerljung et al.

Cite

CITATION STYLE

APA

Ekerljung, L., Lennartsson, J., & Gedda, L. (2012). The HER2-Binding Affibody Molecule (ZHER2:342)2 Increases Radiosensitivity in SKBR-3 Cells. PLoS ONE, 7(11). https://doi.org/10.1371/journal.pone.0049579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free